Glycine is one of the most abundant amino acids in the body — critical for collagen, sleep, gut lining, detox, and methylation. Most people eating a modern diet are chronically deficient. Research and educational purposes only.
7 types of sihr reference now in the Ruqyah section. B12/K2/D3 stack guide now in Cheat Sheet. For research and educational use only.
GLP-1 receptor agonists suppress TNF-α, IL-6, IL-1β — the primary drivers of autoimmune joint destruction. Researchers are finding significant benefit for rheumatic and autoimmune conditions beyond their primary metabolic indication.
"Peptides cause cancer" is one of the most repeated fears — and one of the least supported by actual biology. The truth is a genuine tug-of-war between competing mechanisms.
Active cancer diagnosis: consult oncologist before any growth-promoting peptides. Healthy individual with no known malignancy: the fear is largely unsupported by evidence. Context, dose, and individual biology are everything. Always verify with bloodwork.
A cheap, unpatentable byproduct of wood pulp manufacturing — penetrates skin instantly, dragging other molecules into the bloodstream. Studied for cancer, brain injury, arthritis, wound healing, and bladder disease. FDA-approved for one condition. Not mainstream because it can't be patented.
⚠ CLEAN SKIN ONLY — it carries whatever is on your skin. Pharmaceutical grade 99.9% only. Industrial grade = toxic impurities delivered straight to tissue.
Most people with Hashimoto's are handed a Levothyroxine prescription and told it's a lifelong condition. What they're not told: the attack is coming from the immune system — and if you address the root cause, driving TPO antibodies toward zero and restoring full thyroid function is achievable. Here's what the research supports.
Source: Trevor Bachmeyer — A protocol combining Retatrutide + KPV + BPC-157 + Thymosin Alpha-1 + Nicotine Patch in an experimental autoimmune thyroiditis (EAT) murine model produced remarkable results over 12 weeks: autoantibody titers reduced by 60%, thyroid histology improved by 55%, TSH/T4 normalized, and inflammation dropped by 50% — with 100% survival and zero adverse effects.
| Outcome | Control | Protocol | Result |
|---|---|---|---|
| Anti-Tg/Anti-TPO (AU/mL) | 450 ± 40 | 180 ± 20 | ↓ 60% *** |
| Thyroid Histology Score (0–4) | 3.2 ± 0.3 | 1.4 ± 0.2 | ↓ 55% *** |
| TNF-α / IL-6 (pg/mL) | 120 ± 11 | 60 ± 6 | ↓ 50% *** |
| TSH / T4 | Abnormal | Normalized ** | ✓ |
| HOMA-IR (Insulin Sensitivity) | 1.82 ± 0.18 | Normalized ** | ↓ 57% |
| ROS / MDA (Oxidative Stress) | High | ROS ↓45% / MDA ↓40% | *** / ** |
Research and educational use only. Not medical advice. Work with a functional medicine physician or endocrinologist open to root-cause protocols, not just TSH management.

| Marker | Concerning | Optimal |
|---|---|---|
| Fasting Insulin | >8 µIU/mL | <5 µIU/mL |
| HOMA-IR | >2.0 | <1.5 |
| Fasting Glucose | >100 mg/dL | <100 mg/dL |
| Triglycerides | >150 mg/dL | <150 mg/dL |
Lilly's Phase 1b: Eloralintide (selective amylin receptor agonist) + Tirzepatide produces bariatric-surgery-level weight loss faster than anything seen in a drug trial.
| Regimen | Wks | Loss |
|---|---|---|
| Placebo + TZP 5mg | 16 | -10.0% |
| Elora 9mg + TZP 5mg | 16 | -20.5% |
| Elora 9mg + TZP 15mg | 32 | -29.0% 🔥 |
Magnesium L-Threonate is the only form of magnesium clinically proven to cross the blood-brain barrier efficiently. At the synapse, magnesium regulates NMDA receptor activity — reducing overactivation, calming neurological noise, and enabling deeper transitions into slow-wave sleep.
Switching between Tirzepatide and Retatrutide isn't simple — different half-lives, receptor profiles, washout windows. Never mix Tirz and Reta. One at a time.


Larazotide — being explored for long COVID at Harvard. Improves tight junction function, reduces "leaky gut," may prevent spike protein from perpetuating systemic inflammation.

BPC-157 + KPV + Larazotide Acetate + Zinc Carnosine — repairing, calming, sealing, protecting.
🔬 NCBI PMC — Larazotide Research ↗ATX304 — oral AMPK activator studied alongside GLP-1s for weight maintenance post-discontinuation + emerging MASLD/fatty liver data. Early-stage — discuss with your doctor.

How myostatin inhibition pairs with Tirzepatide to preserve lean muscle during aggressive fat loss. We're all about to be lean here.


Does GLP research cause blindness? Two perspectives on the headlines — one cautious, one reassuring. The risk (Non-Arteritic Ischemic Optic Neuropathy) applies specifically to people with pre-existing diabetic retinopathy or neuropathy. Read both and decide.


The regulatory and supply landscape for Retatrutide is shifting. Here is what we know, what it means for researchers, and how to stay ahead of it.

Science-backed guide to peptides — mechanisms, dosing protocols, stacking strategies, and clinical research. Now available on Amazon.
📖 Get it on Amazon ↗Pep-Pedia — free, searchable encyclopedia covering peptides, mechanisms, research, dosing references.
🧬 Visit Pep-Pedia ↗Three complete guides in one 82-page searchable document: Part 1 — Complete Peptide Reference (80+ compounds). Part 2 — Storage & Shelf Life Guide. Part 3 — Reconstitution Guide.
📥 DOWNLOAD PDF GUIDE ↗Wallet setup, buying coins, sending payment, avoiding mistakes.

Full Tesamorelin research reference — gelling fixes, refrigeration guidance, 10/20/30 dosing protocol, info guide, and reta retest. For research use only.
Peter Magic, founder of Janoshik — the gold standard of independent peptide testing — breaks down sterility testing, heavy metals, endotoxins, and how to spot a fake COA. Required watching before buying from any vendor.